Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 29, 2026
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.
Journal: Journal for immunotherapy of cancer
Published: November 09, 2023
Global Emergency Medicine: A Scoping Review of the Literature from 2022.
Journal: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
Published: July 01, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies.
Journal: Molecular cancer therapeutics
Published: June 02, 2023
Global emergency medicine: A scoping review of the literature from 2021.
Journal: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
Published: June 14, 2022
Global emergency medicine: A scoping review of the literature from 2020.
Journal: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
Published: June 07, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.
Journal: Journal of medicinal chemistry
Published: March 23, 2021
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.
Journal: BMC infectious diseases
Published: February 08, 2021
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.
Journal: Nature communications
Published: October 28, 2019
Last Updated: 09/26/2026